price

Noted health economist Uwe Reinhardt, in a JAMA viewpoint, suggests that price transparency is a "disruptive innovation" for health care, particularly when linked to reference pricing.  This assumes, however, that patients are more interested in price than in a relationship with a particular doctor, and that consumers have sufficient incentives to care about price.